AMSTERDAM — A novel gastric electrical stimulation device can potentially improve glucose levels and induce weight loss in obese patients with type 2 diabetes on oral antihyperglycemic therapy, Dr. Christoph Rosak reported in a poster presentation at the annual meeting of the European Association for the Study of Diabetes.
PREVIEW